Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Neonatal Respiratory Health Research, Cystic Fibrosis Research Advances, and Asthma and respiratory diseases.
Association of Lung Quantitative CT Scan Textures With Systemic Inflammation and Mortality in COPD
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
Structural and genetic diversity in the secreted mucins MUC5AC and MUC5B
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS
Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study
Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD
Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema
Altitude effect on COPD in SPIROMICS cohort
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
Clinical Phenotypes of Atopy and Asthma in COPD
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
<p>Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis</p>
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study